Approval clinical trial showing that treatment with Lonsurf plus bevacizumab resulted in statistically significant and clinically meaningful improvements in overall survival in patients with previously […]

FDA Approves Izervay (avacincaptad pegol) Intravitreal Solution for the Treatment for Geographic Atrophy TOKYO, Aug. 5, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President […]

June 28, 2023 — Today, the U.S. Food and Drug Administration approved Lantidra, the first allogeneic (donor) pancreatic islet cellular therapy made from deceased donor […]

FDA Approves Opvee (nalmefene hydrochloride) Prescription Nasal Spray to Reverse Opioid Overdose May 22, 2023 — Today, the U.S. Food and Drug Administration approved Opvee, […]

FDA Approves Arexvy (respiratory syncytial virus vaccine, adjuvanted) Respiratory Syncytial Virus (RSV) Vaccine for Older Adults May 3, 2023 — GSK plc (LSE/NYSE: GSK) today […]

FDA Approves Abilify Asimtufii (aripiprazole) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of Bipolar I Disorder in Adults April 28, 2023 — Otsuka […]

FDA Approves Joenja (leniolisib) for the Treatment of Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS) LEIDEN, The Netherlands, March 24, 2023 /PRNewswire/ — Pharming Group N.V. […]

FDA Approves Rezzayo (rezafungin for injection) for the Treatment of Candidemia and Invasive Candidiasis SAN DIEGO & PARSIPPANY, N.J.–(BUSINESS WIRE)– March 22, 2023 — Cidara […]

La administración Biden se enfrenta a la creciente presión de los estados para que les permita importar medicamentos de Canadá con el fin de reducir […]

Tim Buck knows by heart how many people died from drug overdoses in his North Carolina county last year: 10. The year before it was […]